NEW YORK, July 21, 2010 – SK Capital Partners, a transformational private equity firm, today announced that it has expanded its investment team with the additions of Aaron Davenport and Jim Marden as Managing Directors. Both Mr. Davenport and Mr. Marden previously led the healthcare investing effort at Arsenal Capital Partners, where they worked closely with Barry Siadat and Jack Norris, two Managing Directors at SK Capital.
A breakdown of the market action, with Brian Belski, Oppenheimer & Co.; Clark Winter, SK Capital Partners; and CNBC's Maria Bartiromo.
13 August 2009 20:24 [Source: ICIS news]
By Joseph Chang
NEW YORK (ICIS news)--The volume of merger and acquisition (M&A) activity in the global chemicals industry plunged in the first half of 2009 and will be down significantly for the entire year despite some sequential improvement, Peter Young, president of Young & Partners, said on Thursday.
"The number of completed deals greater than $25m (€17.5m) in value was only four in the first quarter and seven in the second quarter, finally breaking the string of six consecutive quarters of lower numbers of completed deals," Young said in an interview with ICIS.
A total of 11 deals were completed in the first half of 2009, well off the pace of 55 for all of 2008, he noted.
Depressed earnings for buyers and target businesses, lack of agreements on price, the lack of debt financing, uncertain economic forecasts and fewer buyers suppressed the number of completed transactions, said the investment banker.
"The escalating financial crisis had a significant effect on the ability of financial buyers to acquire chemical industry assets," Young said.
Young noted that the sale of Solutia's nylon business to SK Capital for $50m was the only chemical business sold to a financial buyer in the first half of the year.
"As a result of the prolonged debt crisis, the economic recession and retreating buyers, and valuation disagreements, we believe that the chemical M&A market in 2009 will be a lot slower than 2008," he said.
Through the first half, $21.1bn in deals were completed, compared with $40bn for all of 2008, according to Young & Partners.
However, US-based Dow Chemical's acquisition of
($1 = €0.70)
Look for a feature on chemical industry M&As in the 14 September issue of ICIS Chemical Business
To discuss issues facing the chemical industry go to ICIS connect
Bookmark Paul Hodges’ Chemicals and the Economy Blog
By: Joseph Chang
+1 713 525 2653
New owners of former Solutia nylon business draw on deep experience
NEW YORK, June 1, 2009 – SK Capital Partners, a transformational private investment firm, today announced that it has completed its previously announced acquisition of Solutia Inc.’s (NYSE: SOA) integrated nylon business, a leading supplier and manufacturer of nylon chemicals, plastics and fibers. The company had approximately $1.8 billion in revenues in 2008.
"The new shift is whether or not we're being more productive with the same amount of assets," Clark Winter from SK Capital Partners said on the US earnings season. "For years it was all about better returns on the same assets, better returns on the same portfolio."
SK Capital Partners, a transformational private investment firm, today announced that it has further strengthened its investment team with the appointment of Jack Norris as a Managing Director.
How to Adapt to Market Changes - Finding the right 'tools' for the markets.
SK Capital Partners, a transformational private investment firm, announced that it will acquire Solutia Inc.’s (NYSE: SOA) integrated nylon business, a leading supplier and manufacturer of nylon chemicals, plastics and fibers. The acquisition reflects SK Capital Partners’ investment strategy of identifying businesses that can generate superior returns through a combination of strategic repositioning, enhanced management and operational execution.
|
|
Clark Winter, chief investment officer at SK Capital Partners, talks with Bloomberg's Erik Schatzker and Julie Hyman about the outlook for the equity market. Winter also discusses mark-to-market accounting, private equity opportunities and the importance of leadership. |
The market saw triple-digit gains Wednesday after big declines earlier in the week. Clark Winter, an author and investor, and Louis Stanasolovich, of Legend Advisors, share their insight.
The market saw triple-digit gains Wednesday after big declines earlier in the week. Clark Winter, an author and investor, and Louis Stanasolovich, of Legend Advisors, share their insight.
Private equity investor Clark Winter explains to Dow Jones Newswires' Simon Constable how the U.S. investment scenario looks a lot like that of Latin countries in prior meltdowns. Plus, how savvy investors might want to allocate their assets.
Mr. Winter, said, “The current market provides an unprecedented opportunity to identify under valued assets and bring talented management teams together to drive substantial value creation. Even in tumultuous times, hard work, homework and insightful leadership have great opportunities at hand. I am excited to participate in this value creation at SK Capital Partners.”
SK Capital Partners LP, a buyout firm started last year by one of the founders of Arsenal Capital Partners, has completed its first deal, buying acrylic sheeting maker Aristech Acrylics LLC from Japanese conglomerate Mitsubishi Corp.
"While we remain focused on profitability, which underpins our stability and prosperity for our employees, we now can actively seek out new opportunities to develop the company," said David Knowles, president of Aristech.
In speaking with MergersUnleashed, Siadat said Aristech was a noncore asset with a strong management team, and he had been interested in acquiring the stand-alone division “for some time.” Aristech’s management team will also invest alongside SK Capital in this LBO. “A good knowledge of the operations allowed us to connect with the management team,” Siadat added.
Private equity firm SK Capital Partners LP has purchased Aristech Acrylics LLC from Mitsubishi Corp., the companies announced Wednesday. The acquisition price wasn't disclosed.
FLORENCE - Aristech Acrylics LLC, headquartered in Florence, has been acquired by SK Capital Partners, LP, a New York private equity firm specializing in the specialty chemical industry.
Global trends of increased focus on healthy living and wellness, improving diets, population growth and the need for environmentally compatible products continue to shape the role of the specialty chemicals industry. Timothy Zappala, President and CEO of Vertellus Specialties and Barry Siadat, Managing Director of Arsenal Capital Partners discuss how Vertellus Specialties, Inc. is capitalizing on these life science trends.
“Our investment strategy is to invest in businesses that we understand.”
PRIVATE-EQUITY firm Arsenal Capital Partners is taking aim at the specialty chemical industry, snapping up companies with high potential and refocusing efforts on marketing and innovation. The firm could eventually combine a number of its acquisitions into a company to take public.
Over the next three years, AlliedSignal Inc. plans to grow revenues 8% a year through internal growth-not including the potential acquisition ofAMPInc.,the $5.75 billion industry-leading connector manufacturer. Most of that growth will come from new product development, boosting revenues to $18.5billion by the year 2000. Based on the company's performance since Lawrence A. Bossidy became CEO in 1991,the lofty goals seem well within range.
